2-(9,9-dimethylfluoren-2-yl)-4-methyl-6-naphthalen-2-yl-1,3,5-triazine;2-(9,9-dimethylfluoren-2-yl)-4-methyl-6-(4-phenylphenyl)-1,3,5-triazine;2-(9,9-dimethylfluoren-2-yl)-4-methyl-6-phenyl-1,3,5-triazine;2-methyl-4-(4-phenylphenyl)quinazoline;2-methyl-4-phenylquinoline;4-methyl-2-phenylquinoline;8-(4-methylphenyl)quinoline
C154H124N14 — CID 158028416
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-(9,9-dimethylfluoren-2-yl)-4-methyl-6-naphthalen-2-yl-1,3,5-triazine;2-(9,9-dimethylfluoren-2-yl)-4-methyl-6-(4-phenylphenyl)-1,3,5-triazine;2-(9,9-dimethylfluoren-2-yl)-4-methyl-6-phenyl-1,3,5-triazine;2-methyl-4-(4-phenylphenyl)quinazoline;2-methyl-4-phenylquinoline;4-methyl-2-phenylquinoline;8-(4-methylphenyl)quinoline
2-(9,9-dimethylfluoren-2-yl)-4-methyl-6-naphthalen-2-yl-1,3,5-triazine;2-(9,9-dimethylfluoren-2-yl)-4-methyl-6-(4-phenylphenyl)-1,3,5-triazine;2-(9,9-dimethylfluoren-2-yl)-4-methyl-6-phenyl-1,3,5-triazine;2-methyl-4-(4-phenylphenyl)quinazoline;2-methyl-4-phenylquinoline;4-methyl-2-phenylquinoline;8-(4-methylphenyl)quinoline (PubChem CID 158028416) has the molecular formula C154H124N14 and a molecular weight of 2170.78 g/mol. Its IUPAC name is 2-(9,9-dimethylfluoren-2-yl)-4-methyl-6-naphthalen-2-yl-1,3,5-triazine;2-(9,9-dimethylfluoren-2-yl)-4-methyl-6-(4-phenylphenyl)-1,3,5-triazine;2-(9,9-dimethylfluoren-2-yl)-4-methyl-6-phenyl-1,3,5-triazine;2-methyl-4-(4-phenylphenyl)quinazoline;2-methyl-4-phenylquinoline;4-methyl-2-phenylquinoline;8-(4-methylphenyl)quinoline.
Molecular Properties
| Compound Name | 2-(9,9-dimethylfluoren-2-yl)-4-methyl-6-naphthalen-2-yl-1,3,5-triazine;2-(9,9-dimethylfluoren-2-yl)-4-methyl-6-(4-phenylphenyl)-1,3,5-triazine;2-(9,9-dimethylfluoren-2-yl)-4-methyl-6-phenyl-1,3,5-triazine;2-methyl-4-(4-phenylphenyl)quinazoline;2-methyl-4-phenylquinoline;4-methyl-2-phenylquinoline;8-(4-methylphenyl)quinoline |
|---|---|
| PubChem CID | 158028416 |
| Molecular Formula | C154H124N14 |
| Molecular Weight | 2170.78 g/mol |
| Exact Mass | 2169.01 |
| IUPAC Name | 2-(9,9-dimethylfluoren-2-yl)-4-methyl-6-naphthalen-2-yl-1,3,5-triazine;2-(9,9-dimethylfluoren-2-yl)-4-methyl-6-(4-phenylphenyl)-1,3,5-triazine;2-(9,9-dimethylfluoren-2-yl)-4-methyl-6-phenyl-1,3,5-triazine;2-methyl-4-(4-phenylphenyl)quinazoline;2-methyl-4-phenylquinoline;4-methyl-2-phenylquinoline;8-(4-methylphenyl)quinoline |
| SMILES | Cc1cc(-c2ccccc2)c2ccccc2n1.Cc1cc(-c2ccccc2)nc2ccccc12.Cc1ccc(-c2cccc3cccnc23)cc1.Cc1nc(-c2ccc(-c3ccccc3)cc2)c2ccccc2n1.Cc1nc(-c2ccc(-c3ccccc3)cc2)nc(-c2ccc3c(c2)C(C)(C)c2ccccc2-3)n1.Cc1nc(-c2ccc3c(c2)C(C)(C)c2ccccc2-3)nc(-c2ccc3ccccc3c2)n1.Cc1nc(-c2ccccc2)nc(-c2ccc3c(c2)C(C)(C)c2ccccc2-3)n1 |
| InChI | InChI=1S/C31H25N3.C29H23N3.C25H21N3.C21H16N2.3C16H13N/c1-20-32-29(23-15-13-22(14-16-23)21-9-5-4-6-10-21)34-30(33-20)24-17-18-26-25-11-7-8-12-27(25)31(2,3)28(26)19-24;1-18-30-27(21-13-12-19-8-4-5-9-20(19)16-21)32-28(31-18)22-14-15-24-23-10-6-7-11-25(23)29(2,3)26(24)17-22;1-16-26-23(17-9-5-4-6-10-17)28-24(27-16)18-13-14-20-19-11-7-8-12-21(19)25(2,3)22(20)15-18;1-15-22-20-10-6-5-9-19(20)21(23-15)18-13-11-17(12-14-18)16-7-3-2-4-8-16;1-12-7-9-13(10-8-12)15-6-2-4-14-5-3-11-17-16(14)15;1-12-11-15(13-7-3-2-4-8-13)14-9-5-6-10-16(14)17-12;1-12-11-16(13-7-3-2-4-8-13)17-15-10-6-5-9-14(12)15/h4-19H,1-3H3;4-17H,1-3H3;4-15H,1-3H3;2-14H,1H3;3*2-11H,1H3 |
| InChIKey | FGWPRNVZZCQSDC-UHFFFAOYSA-N |
| XLogP | 38.18 |
| TPSA | 180.46 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 14 |
| Rotatable Bonds | 12 |
| Heavy Atoms | 168 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2170.78 |
| LogP ≤ 5 | 38.18 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 14 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158028416 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.